)
Edge20 Mar 2026
Tetra Pak: The Shape of Innovation
The story of Tetra Pak, the Rausing family, and how a paper tetrahedron gave rise to a company that now delivers almost 180 billion packages a year.
Jasper Therapeutics
Jasper Therapeutics (JSPR) investor relations material
Jasper Therapeutics Q4 2025 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q4 2025 earnings summary30 Mar, 2026
Executive summary
Positive clinical data for briquilimab in chronic spontaneous urticaria (CSU), chronic inducible urticaria (CIndU), and asthma, supporting further development.
CEO transition with Jeet Mahal appointed to lead the next phase of clinical growth.
Internal investigation into anomalous clinical data found no drug product issues and led to process improvements.
Financial highlights
Cash and cash equivalents at year-end 2025 totaled $28.7 million, down from $71.6 million at year-end 2024.
Net loss for Q4 2025 was $9.1 million, and for the full year 2025 was $75.8 million, compared to $71.3 million in 2024.
Research and development expenses for Q4 2025 were $11.4 million; full year R&D was $63.1 million.
General and administrative expenses for Q4 2025 were $4.5 million; full year G&A was $20.8 million.
Net loss per share was $0.32 for Q4 2025 and $3.95 for the year.
Outlook and guidance
Phase 2b/3 study in CSU planned to commence in the second half of 2026, pending capital availability.
Further clinical development in asthma contingent on competitive landscape, partnerships, and funding.
Site selection updates after BEACON investigation
Funding strategy for the Phase 2b/3 CSU trial
Strategic partnership plans for asthma
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Jasper Therapeutics
- Briquilimab delivers rapid urticaria control; pivotal trials and equity financing are planned.JSPR
TD Cowen 46th Annual Health Care Conference2 Mar 2026 - Briquilimab delivers rapid, durable efficacy in urticaria and asthma with strong safety and market potential.JSPRCorporate presentation2 Mar 2026
- Briquilimab targets mast cell depletion in CSU, CIndU, and asthma, with key data expected in 2024.JSPRJefferies 2024 Global Healthcare Conference1 Feb 2026
- Key phase II urticaria and asthma study milestones for briquilimab expected in Q4.JSPRH.C. Wainwright 26th Annual Global Investment Conference 202421 Jan 2026
- Key data from briquilimab trials in CSU and CIndU expected in Q4, with asthma trial also advancing.JSPR2024 Cantor Fitzgerald Global Healthcare Conference20 Jan 2026
- BEACON study data on briquilimab's efficacy and safety expected in Q4, guiding next trial steps.JSPRTD Cowen Chronic Urticaria Summit20 Jan 2026
- Briquilimab achieved 93% response and strong safety in CIndU; more data expected in 2025.JSPRStudy Result19 Jan 2026
- Briquilimab shows strong efficacy in urticaria, with pivotal Beacon study results expected soon.JSPRStifel 2024 Healthcare Conference13 Jan 2026
- Key CSU trial data in January will highlight efficacy, safety, and dosing advantages.JSPR7th Annual Evercore ISI HealthCONx Conference12 Jan 2026
Next Jasper Therapeutics earnings date
Q1 202612 May, 2026
Jasper Therapeutics
Next Jasper Therapeutics earnings date
Q1 202612 May, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Explore our global coverage